Wilton Resources Corporation Limited (SGX:5F7)
Singapore · Delayed Price · Currency is SGD 0.0080
0.00 (0.00%)
At close: Aug 11, 2025
Orchard Therapeutics Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 1,341 | 3,990 | 5,396 | 4,829 | 6,353 | Upgrade | |
Revenue Growth (YoY) | -66.39% | -26.06% | 11.74% | -23.99% | 50.52% | Upgrade |
Cost of Revenue | 852 | 3,559 | 4,006 | 3,600 | 4,831 | Upgrade |
Gross Profit | 489 | 431 | 1,390 | 1,229 | 1,522 | Upgrade |
Selling, General & Admin | 50,096 | 43,979 | 40,184 | 34,943 | 57,055 | Upgrade |
Other Operating Expenses | 27,174 | 31,013 | 12,005 | 9,649 | 9,273 | Upgrade |
Operating Expenses | 77,270 | 74,992 | 52,189 | 44,592 | 66,328 | Upgrade |
Operating Income | -76,781 | -74,561 | -50,799 | -43,363 | -64,806 | Upgrade |
Interest Expense | -31,143 | -136,396 | -75,469 | -2,254 | -24,805 | Upgrade |
Interest & Investment Income | 696 | 688 | 421 | 599 | 958.67 | Upgrade |
Currency Exchange Gain (Loss) | -14,558 | 1,821 | - | -4,018 | 70.67 | Upgrade |
Other Non Operating Income (Expenses) | -1,234 | -1,392 | -29,097 | -3,455 | -895.33 | Upgrade |
EBT Excluding Unusual Items | -123,020 | -209,840 | -154,944 | -52,491 | -89,477 | Upgrade |
Other Unusual Items | - | 161,341 | 3 | 66,546 | - | Upgrade |
Pretax Income | -123,020 | -48,499 | -154,941 | 14,055 | -89,477 | Upgrade |
Income Tax Expense | 4,793 | 4,733 | - | - | - | Upgrade |
Earnings From Continuing Operations | -127,813 | -53,232 | -154,941 | 14,055 | -89,477 | Upgrade |
Minority Interest in Earnings | 1,087 | 15,924 | 4,593 | 1,134 | 2,549 | Upgrade |
Net Income | -126,726 | -37,308 | -150,348 | 15,189 | -86,929 | Upgrade |
Net Income to Common | -126,726 | -37,308 | -150,348 | 15,189 | -86,929 | Upgrade |
Shares Outstanding (Basic) | 2,624 | 2,624 | 2,611 | 2,568 | 2,539 | Upgrade |
Shares Outstanding (Diluted) | 2,624 | 2,624 | 2,611 | 2,592 | 2,539 | Upgrade |
Shares Change (YoY) | - | 0.49% | 0.73% | 2.12% | 4.18% | Upgrade |
EPS (Basic) | -48.30 | -14.22 | -57.58 | 5.92 | -34.24 | Upgrade |
EPS (Diluted) | -48.30 | -14.22 | -57.58 | 5.86 | -34.25 | Upgrade |
Free Cash Flow | -35,914 | -63,997 | -67,927 | -78,565 | -88,392 | Upgrade |
Free Cash Flow Per Share | -13.69 | -24.39 | -26.01 | -30.31 | -34.82 | Upgrade |
Gross Margin | 36.46% | 10.80% | 25.76% | 25.45% | 23.96% | Upgrade |
Operating Margin | -5725.65% | -1868.70% | -941.42% | -897.97% | -1020.03% | Upgrade |
Profit Margin | -9450.11% | -935.04% | -2786.29% | 314.54% | -1368.24% | Upgrade |
Free Cash Flow Margin | -2678.15% | -1603.93% | -1258.84% | -1626.94% | -1391.27% | Upgrade |
EBITDA | -72,507 | -70,287 | -47,660 | -40,099 | -61,653 | Upgrade |
D&A For EBITDA | 4,274 | 4,274 | 3,139 | 3,264 | 3,153 | Upgrade |
EBIT | -76,781 | -74,561 | -50,799 | -43,363 | -64,806 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.